Methotrexate and Leflunomide Increase Risks for Adverse Pregnancy Outcomes in RA
Rheumatology Advisor,
The possibility of adverse pregnancy outcomes was increased among patients with rheumatoid arthritis (RA) taking methotrexate…
The possibility of adverse pregnancy outcomes was increased among patients with rheumatoid arthritis (RA) taking methotrexate…
Highlights: The study evaluated effects of Antirheumatic drugs on pregnant women diagnosed with rheumatoid arthritis Drugs…
Treatment with methotrexate (MTX) and leflunomide (LEF) within three months before conception was associated with an increased…
Being treated with methotrexate (MTX) and leflunomide (LEF) within 3 months prior to conception was associated with an…